» Articles » PMID: 20554025

Tickets to the Brain: Role of CCR2 and CX3CR1 in Myeloid Cell Entry in the CNS

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2010 Jun 18
PMID 20554025
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Myeloid cells are mediators of central nervous system (CNS) damage and recovery in neuroinflammatory and neurodegenerative disorders. Besides endogenous myelomonocytic cell populations that reside in the brain already during development, newly migrated leukocytes are considered as important disease modulators in the adult brain. Thus, understanding of myeloid cell recruitment is pivotal for manipulating immune cell entry into the CNS and potentially reducing disease burden. Before myeloid cells engraft in the brain, they first tether to and roll on the activated brain endothelium, then they firmly adhere and eventually transmigrate into the damaged brain where they execute effector functions and differentiate into cells with microglia-like features. These steps are mainly regulated by adhesion molecules and by chemokines and their cognate receptors. Due to recent advances in our understanding of monocyte heterogeneity, the interest in chemokine receptors has significantly increased. Among others, the presence of the chemokine receptors CCR2 and CX(3)CR(1) is considered to be critical for both myeloid cell trafficking along inflamed vessels and subsequent accumulation in the brain. Therefore, these molecules present viable targets for therapeutic manipulations of myeloid cells destined for the CNS.

Citing Articles

Inflammatory changes in the choroid plexus following subarachnoid hemorrhage: the role of innate immune receptors and inflammatory molecules.

Solar P, Brazda V, Bares M, Zamani A, EmamiAref P, Joukal A Front Cell Neurosci. 2025; 18():1525415.

PMID: 39839349 PMC: 11747387. DOI: 10.3389/fncel.2024.1525415.


Exploring CX3CR1 as a prognostic biomarker and immunotherapeutic target in sarcoma.

Li T, Li X, Kang P, Zhao J Transl Oncol. 2025; 53:102283.

PMID: 39837057 PMC: 11787715. DOI: 10.1016/j.tranon.2025.102283.


Monocyte-derived macrophages act as reinforcements when microglia fall short in Alzheimer's disease.

Abellanas M, Purnapatre M, Burgaletto C, Schwartz M Nat Neurosci. 2025; 28(3):436-445.

PMID: 39762659 DOI: 10.1038/s41593-024-01847-5.


Navigating the nano-bio immune interface: advancements and challenges in CNS nanotherapeutics.

Moulton C, Baroni A, Quagliarini E, Leone L, Digiacomo L, Morotti M Front Immunol. 2024; 15:1447567.

PMID: 39600701 PMC: 11588692. DOI: 10.3389/fimmu.2024.1447567.


MicroRNA-195-5p Inhibits Intracerebral Hemorrhage-Induced Inflammatory Response and Neuron Cell Apoptosis.

Tsai Y, Chang C, Chong Y, Wu C, Tsai H, Cheng T Int J Mol Sci. 2024; 25(19).

PMID: 39408651 PMC: 11476780. DOI: 10.3390/ijms251910321.